Alcresta Therapeutics Virtual Patent Marking
This page is intended to serve as notice under 35 U.S.C. § 287(a).
The following U.S. patents apply to Alcresta’s product RELiZORB®:
U.S. Patent No. 9,668,942
U.S. Patent No. 9,687,420
U.S. Patent No. 9,775,783
U.S. Patent No. 9,775,784
U.S. Patent No. 10,258,590
US Patent No. 10,632,047
US Patent No. 10,828,239
US Patent No. 11,045,440
Other Patents Pending